APO RESEARCH · REPORT
Irreversible Electroporation Ablators
Irreversible electroporation is a soft tissue ablation technique using ultra short but strong electrical fields to create permanent and hence lethal Nano pores in the cell membrane, to disrupt the cellular homeostasis. The resulting cell death results from apoptosis and not necrosis as in all other thermal or radiation based ablation techniques. The main use of IRE lies in tumor ablation in regions where precision and conservation of the extracellular matrix, blood flow and nerves are of importance. The technique is in an experimental stage and has not been approved for use outside of clinical trials. IRE is used in the NanoKnife System.
Product & engineering
Understand the product.
Irreversible electroporation is a soft tissue ablation technique using ultra short but strong electrical fields to create permanent and hence lethal Nano pores in the cell membrane, to disrupt the cellular homeostasis. The resulting cell death results from apoptosis and not necrosis as in all other thermal or radiation based ablation techniques. The main use of IRE lies in tumor ablation in regions where precision and conservation of the extracellular matrix, blood flow and nerves are of importance. The technique is in an experimental stage and has not been approved for use outside of clinical trials. IRE is used in the NanoKnife System.
Selected research
Market Analysis & Forecast
Global Irreversible Electroporation Ablators Market Analysis and Forecast 2026-2032
Market perspective
Irreversible electroporation is a soft tissue ablation technique using ultra short but strong electrical fields to create permanent and hence lethal Nano pores in the cell membrane, to disrupt the cellular homeostasis. The resulting cell death results from apoptosis and not necrosis as in all other thermal or radiation based ablation techniques. The main use of IRE lies in tumor ablation in regions where precision and conservation of the extracellular matrix, blood flow and nerves are of importance. The technique is in an experimental stage and has not been approved for use outside of clinical trials. IRE is used in the NanoKnife System.
The world's leading manufacturers of irreversible electroporation ablators are AngioDynamics and Pulse Biosciences. North America is the largest consumption place, with a consumption market share nearly 56%. Following North America, Europe is the second largest consumption place with the consumption market share of 25%.
This report presents an overview of global market for Irreversible Electroporation Ablators, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
Read the full market overview
This report researches the key producers of Irreversible Electroporation Ablators, also provides the sales of main regions and countries. Of the upcoming market potential for Irreversible Electroporation Ablators, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Irreversible Electroporation Ablators sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Irreversible Electroporation Ablators market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Irreversible Electroporation Ablators sales, projected growth trends, production technology, application and end-user industry.
Irreversible Electroporation Ablators Segment by Company
AngioDynamics
Pulse Biosciences
Irreversible Electroporation Ablators Segment by Type
Generator
Part
Service
Irreversible Electroporation Ablators Segment by Application
Liver
Pancreas
Prostate
Others
Irreversible Electroporation Ablators Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Irreversible Electroporation Ablators market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Irreversible Electroporation Ablators and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Irreversible Electroporation Ablators.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Irreversible Electroporation Ablators in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Irreversible Electroporation Ablators manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Irreversible Electroporation Ablators sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Generator
- Part
- Service
Applications
- Liver
- Pancreas
- Prostate
- Others
Companies covered
- AngioDynamics
- Pulse Biosciences
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Irreversible Electroporation Ablators Market by Type
- 1.2.1 Global Irreversible Electroporation Ablators Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Generator
- 1.2.3 Part
- 1.2.4 Service
- 1.3 Irreversible Electroporation Ablators Market by Application
- 1.3.1 Global Irreversible Electroporation Ablators Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Liver
- 1.3.3 Pancreas
- 1.3.4 Prostate
- 1.3.5 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Irreversible Electroporation Ablators Market Dynamics
- 2.1 Irreversible Electroporation Ablators Industry Trends
- 2.2 Irreversible Electroporation Ablators Industry Drivers
- 2.3 Irreversible Electroporation Ablators Industry Opportunities and Challenges
- 2.4 Irreversible Electroporation Ablators Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Irreversible Electroporation Ablators Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Irreversible Electroporation Ablators Revenue by Region
- 3.2.1 Global Irreversible Electroporation Ablators Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Irreversible Electroporation Ablators Revenue by Region (2021-2026)
- 3.2.3 Global Irreversible Electroporation Ablators Revenue by Region (2027-2032)
- 3.2.4 Global Irreversible Electroporation Ablators Revenue Market Share by Region (2021-2032)
- 3.3 Global Irreversible Electroporation Ablators Sales Estimates and Forecasts 2021-2032
- 3.4 Global Irreversible Electroporation Ablators Sales by Region
- 3.4.1 Global Irreversible Electroporation Ablators Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Irreversible Electroporation Ablators Sales by Region (2021-2026)
- 3.4.3 Global Irreversible Electroporation Ablators Sales by Region (2027-2032)
- 3.4.4 Global Irreversible Electroporation Ablators Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Irreversible Electroporation Ablators Revenue by Manufacturers
- 4.1.1 Global Irreversible Electroporation Ablators Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Irreversible Electroporation Ablators Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Irreversible Electroporation Ablators Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Irreversible Electroporation Ablators Sales by Manufacturers
- 4.2.1 Global Irreversible Electroporation Ablators Sales by Manufacturers (2021-2026)
- 4.2.2 Global Irreversible Electroporation Ablators Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Irreversible Electroporation Ablators Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Irreversible Electroporation Ablators Sales Price by Manufacturers (2021-2026)
- 4.4 Global Irreversible Electroporation Ablators Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Irreversible Electroporation Ablators Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Irreversible Electroporation Ablators Manufacturers, Product Type & Application
- 4.7 Global Irreversible Electroporation Ablators Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Irreversible Electroporation Ablators Market CR5 and HHI
- 4.8.2 2025 Irreversible Electroporation Ablators Tier 1, Tier 2, and Tier 3
5 Irreversible Electroporation Ablators Market by Type
- 5.1 Global Irreversible Electroporation Ablators Revenue by Type
- 5.1.1 Global Irreversible Electroporation Ablators Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Irreversible Electroporation Ablators Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Irreversible Electroporation Ablators Revenue Market Share by Type (2021-2032)
- 5.2 Global Irreversible Electroporation Ablators Sales by Type
- 5.2.1 Global Irreversible Electroporation Ablators Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Irreversible Electroporation Ablators Sales by Type (2021-2032) & (k units)
- 5.2.3 Global Irreversible Electroporation Ablators Sales Market Share by Type (2021-2032)
- 5.3 Global Irreversible Electroporation Ablators Price by Type
6 Irreversible Electroporation Ablators Market by Application
- 6.1 Global Irreversible Electroporation Ablators Revenue by Application
- 6.1.1 Global Irreversible Electroporation Ablators Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Irreversible Electroporation Ablators Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Irreversible Electroporation Ablators Revenue Market Share by Application (2021-2032)
- 6.2 Global Irreversible Electroporation Ablators Sales by Application
- 6.2.1 Global Irreversible Electroporation Ablators Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Irreversible Electroporation Ablators Sales by Application (2021-2032) & (k units)
- 6.2.3 Global Irreversible Electroporation Ablators Sales Market Share by Application (2021-2032)
- 6.3 Global Irreversible Electroporation Ablators Price by Application
7 Company Profiles
- 7.1 AngioDynamics
- 7.1.1 AngioDynamics Company Information
- 7.1.2 AngioDynamics Business Overview
- 7.1.3 AngioDynamics Irreversible Electroporation Ablators Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 AngioDynamics Irreversible Electroporation Ablators Product Portfolio
- 7.1.5 AngioDynamics Recent Developments
- 7.2 Pulse Biosciences
- 7.2.1 Pulse Biosciences Company Information
- 7.2.2 Pulse Biosciences Business Overview
- 7.2.3 Pulse Biosciences Irreversible Electroporation Ablators Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Pulse Biosciences Irreversible Electroporation Ablators Product Portfolio
- 7.2.5 Pulse Biosciences Recent Developments
8 North America
- 8.1 North America Irreversible Electroporation Ablators Market Size by Type
- 8.1.1 North America Irreversible Electroporation Ablators Revenue by Type (2021-2032)
- 8.1.2 North America Irreversible Electroporation Ablators Sales by Type (2021-2032)
- 8.1.3 North America Irreversible Electroporation Ablators Price by Type (2021-2032)
- 8.2 North America Irreversible Electroporation Ablators Market Size by Application
- 8.2.1 North America Irreversible Electroporation Ablators Revenue by Application (2021-2032)
- 8.2.2 North America Irreversible Electroporation Ablators Sales by Application (2021-2032)
- 8.2.3 North America Irreversible Electroporation Ablators Price by Application (2021-2032)
- 8.3 North America Irreversible Electroporation Ablators Market Size by Country
- 8.3.1 North America Irreversible Electroporation Ablators Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Irreversible Electroporation Ablators Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Irreversible Electroporation Ablators Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Irreversible Electroporation Ablators Market Size by Type
- 9.1.1 Europe Irreversible Electroporation Ablators Revenue by Type (2021-2032)
- 9.1.2 Europe Irreversible Electroporation Ablators Sales by Type (2021-2032)
- 9.1.3 Europe Irreversible Electroporation Ablators Price by Type (2021-2032)
- 9.2 Europe Irreversible Electroporation Ablators Market Size by Application
- 9.2.1 Europe Irreversible Electroporation Ablators Revenue by Application (2021-2032)
- 9.2.2 Europe Irreversible Electroporation Ablators Sales by Application (2021-2032)
- 9.2.3 Europe Irreversible Electroporation Ablators Price by Application (2021-2032)
- 9.3 Europe Irreversible Electroporation Ablators Market Size by Country
- 9.3.1 Europe Irreversible Electroporation Ablators Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Irreversible Electroporation Ablators Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Irreversible Electroporation Ablators Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Irreversible Electroporation Ablators Market Size by Type
- 10.1.1 China Irreversible Electroporation Ablators Revenue by Type (2021-2032)
- 10.1.2 China Irreversible Electroporation Ablators Sales by Type (2021-2032)
- 10.1.3 China Irreversible Electroporation Ablators Price by Type (2021-2032)
- 10.2 China Irreversible Electroporation Ablators Market Size by Application
- 10.2.1 China Irreversible Electroporation Ablators Revenue by Application (2021-2032)
- 10.2.2 China Irreversible Electroporation Ablators Sales by Application (2021-2032)
- 10.2.3 China Irreversible Electroporation Ablators Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Irreversible Electroporation Ablators Market Size by Type
- 11.1.1 Asia Irreversible Electroporation Ablators Revenue by Type (2021-2032)
- 11.1.2 Asia Irreversible Electroporation Ablators Sales by Type (2021-2032)
- 11.1.3 Asia Irreversible Electroporation Ablators Price by Type (2021-2032)
- 11.2 Asia Irreversible Electroporation Ablators Market Size by Application
- 11.2.1 Asia Irreversible Electroporation Ablators Revenue by Application (2021-2032)
- 11.2.2 Asia Irreversible Electroporation Ablators Sales by Application (2021-2032)
- 11.2.3 Asia Irreversible Electroporation Ablators Price by Application (2021-2032)
- 11.3 Asia Irreversible Electroporation Ablators Market Size by Country
- 11.3.1 Asia Irreversible Electroporation Ablators Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Irreversible Electroporation Ablators Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Irreversible Electroporation Ablators Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Irreversible Electroporation Ablators Market Size by Type
- 12.1.1 SAMEA Irreversible Electroporation Ablators Revenue by Type (2021-2032)
- 12.1.2 SAMEA Irreversible Electroporation Ablators Sales by Type (2021-2032)
- 12.1.3 SAMEA Irreversible Electroporation Ablators Price by Type (2021-2032)
- 12.2 SAMEA Irreversible Electroporation Ablators Market Size by Application
- 12.2.1 SAMEA Irreversible Electroporation Ablators Revenue by Application (2021-2032)
- 12.2.2 SAMEA Irreversible Electroporation Ablators Sales by Application (2021-2032)
- 12.2.3 SAMEA Irreversible Electroporation Ablators Price by Application (2021-2032)
- 12.3 SAMEA Irreversible Electroporation Ablators Market Size by Country
- 12.3.1 SAMEA Irreversible Electroporation Ablators Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Irreversible Electroporation Ablators Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Irreversible Electroporation Ablators Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Irreversible Electroporation Ablators Value Chain Analysis
- 13.1.1 Irreversible Electroporation Ablators Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Irreversible Electroporation Ablators Production Mode & Process
- 13.2 Irreversible Electroporation Ablators Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Irreversible Electroporation Ablators Distributors
- 13.2.3 Irreversible Electroporation Ablators Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst